- Home
- COCH vs LVTX Comparison
COCH vs LVTX Comparison
Compare COCH & LVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COCH
- LVTX
- Stock Information
- Founded
- COCH 1995
- LVTX 2016
- Country
- COCH United States
- LVTX Netherlands
- Employees
- COCH N/A
- LVTX N/A
- Industry
- COCH Blank Checks
- LVTX Biotechnology: Pharmaceutical Preparations
- Sector
- COCH Finance
- LVTX Health Care
- Exchange
- COCH Nasdaq
- LVTX Nasdaq
- Market Cap
- COCH 29.8M
- LVTX 27.9M
- IPO Year
- COCH N/A
- LVTX 2021
- Fundamental
- Price
- COCH $1.48
- LVTX $0.96
- Analyst Decision
- COCH Strong Buy
- LVTX Buy
- Analyst Count
- COCH 3
- LVTX 3
- Target Price
- COCH $8.00
- LVTX $3.33
- AVG Volume (30 Days)
- COCH 26.8K
- LVTX 27.7K
- Earning Date
- COCH 04-01-2025
- LVTX 03-19-2025
- Dividend Yield
- COCH N/A
- LVTX N/A
- EPS Growth
- COCH N/A
- LVTX N/A
- EPS
- COCH N/A
- LVTX N/A
- Revenue
- COCH $278,000.00
- LVTX $7,345,000.00
- Revenue This Year
- COCH N/A
- LVTX $16.68
- Revenue Next Year
- COCH $19.76
- LVTX N/A
- P/E Ratio
- COCH N/A
- LVTX N/A
- Revenue Growth
- COCH 15.35
- LVTX N/A
- 52 Week Low
- COCH $1.17
- LVTX $0.85
- 52 Week High
- COCH $11.46
- LVTX $6.47
- Technical
- Relative Strength Index (RSI)
- COCH 45.07
- LVTX 46.74
- Support Level
- COCH $1.39
- LVTX $0.85
- Resistance Level
- COCH $1.62
- LVTX $0.98
- Average True Range (ATR)
- COCH 0.13
- LVTX 0.05
- MACD
- COCH 0.00
- LVTX 0.01
- Stochastic Oscillator
- COCH 31.03
- LVTX 59.72
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing innovative medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life.
About LVTX LAVA Therapeutics N.V.
LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer.